Intellipharmaceutics International

Intellipharmaceutics International

Intellipharmaceutics International

We operate in the niche market created by the expiration of drug product patents and drug product exclusivity periods.
Type
B2c
Founded
1998
Raised
$4M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,000,000
Post-IPO equity - 2017
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Intellipharmaceutics International makes some noise.